Treatment initiation status of bacteriologically confirmed rifampicin sensitive TB cases.

Neeraj Raizada (52447)
Sunil D. Khaparde (813800)
Virender Singh Salhotra (4419841)
Raghuram Rao (298599)
Aakshi Kalra (4002881)
Soumya Swaminathan (110137)
Ashwani Khanna (813801)
Kamal Kishore Chopra (813802)
M. Hanif (4898863)
Varinder Singh (361039)
K. R. Umadevi (813804)
Sreenivas Achuthan Nair (295840)
Sophie Huddart (4898866)
C. H. Surya Prakash (4898857)
Shalini Mall (4898860)
Pooja Singh (608019)
B. K. Saha (4898869)
Claudia M. Denkinger (501657)
Catharina Boehme (298634)
Sanjay Sarin (710297)

Open link

Publication date

February 2018

DOI

10.1371/journal.pone.0193194.t004

Abstract

Treatment initiation status of bacteriologically confirmed rifampicin sensitive TB cases.</p

Extracted data

We use cookies to provide a better user experience.

Data Protection

Treatment initiation status of bacteriologically confirmed rifampicin sensitive TB cases.

Neeraj Raizada (52447)
Sunil D. Khaparde (813800)
Virender Singh Salhotra (4419841)
Raghuram Rao (298599)
Aakshi Kalra (4002881)
Soumya Swaminathan (110137)
Ashwani Khanna (813801)
Kamal Kishore Chopra (813802)
M. Hanif (4898863)
Varinder Singh (361039)
K. R. Umadevi (813804)
Sreenivas Achuthan Nair (295840)
Sophie Huddart (4898866)
C. H. Surya Prakash (4898857)
Shalini Mall (4898860)
Pooja Singh (608019)
B. K. Saha (4898869)
Claudia M. Denkinger (501657)
Catharina Boehme (298634)
Sanjay Sarin (710297)

Open link

Publication date

February 2018

DOI

10.1371/journal.pone.0193194.t004

Abstract

Treatment initiation status of bacteriologically confirmed rifampicin sensitive TB cases.</p

Extracted data

Arto Yuwono Soeroto (6411806)
Bony Wiem Lestari (6411809)
Prayudi Santoso (6411812)
Lidya Chaidir (103945)
Basti Andriyoko (6411815)
Bachti Alisjahbana (270243)
Reinout van Crevel (60606)
Philip C. Hill (20648)

February 2019

Time between microscopic TB diagnosis and patient presentation for Xpert examination (a), Xpert resu...

Number and proportion of culture positive tuberculosis cases with baseline drug susceptibility testing results, 2007–2016.

Pin-Hui Lee (541722)
Pei-Chun Chan (382044)
Yen-Ting Peng (6541703)
Po-Wei Chu (6541706)
Mei-Hua Wu (6541709)
Ruwen Jou (486507)
Ming-Chih Yu (309977)
Chou-Jui Lin (6541712)
Yi-Wen Huang (83101)
Shun-Tien Chien (382047)
Jen-Jyh Lee (207127)
Chen-Yuan Chiang (139384)

April 2019

Number and proportion of culture positive tuberculosis cases with baseline drug susceptibility testi...

For previously diagnosed rifampicin-resistant tuberculosis patients, time from first recorded rifampicin-resistant tuberculosis diagnosis, HIV status, treatment initiation, and time to treatment by previous second-line treatment status (not weighted for sampling method).

Helen Cox (66086)
Lindy Dickson-Hall (3768895)
Norbert Ndjeka (3768898)
Anja van’t Hoog (300467)
Alison Grant (790918)
Frank Cobelens (109566)
Wendy Stevens (62288)
Mark Nicol (3498533)

February 2017

For previously diagnosed rifampicin-resistant tuberculosis patients, time from first recorded rif...

TB and rifampicin resistant-TB cases detected and initiated on treatment by each of the 4 diagnostic strategies, in a cohort 100,000 persons.

Sunil Khaparde (4419847)
Neeraj Raizada (52447)
Sreenivas Achuthan Nair (295840)
Claudia Denkinger (308888)
Kuldeep Singh Sachdeva (305148)
Chinnambedu Nainarappan Paramasivan (763725)
Virender Singh Salhotra (4419841)
Anna Vassall (144677)
Anja van't Hoog (4419844)

September 2017

TB and rifampicin resistant-TB cases detected and initiated on treatment by each of the 4 diagnos...

Enrollment of presumptive tuberculosis and drug resistant tuberculosis cases in baseline and intervention period of the study.

Kuldeep Singh Sachdeva (305148)
Neeraj Raizada (52447)
Achuthan Sreenivas (527535)
Anna H. van't Hoog (742534)
Susan van den Hof (364556)
Puneet K. Dewan (302713)
Rahul Thakur (52453)
R. S. Gupta (527537)
Shubhangi Kulsange (527538)
Bhavin Vadera (527536)
Ameet Babre (527539)
Christen Gray (121856)
Malik Parmar (305152)
Mayank Ghedia (527541)
Ranjani Ramachandran (110160)
Umesh Alavadi (527540)
Nimalan Arinaminpathy (88497)
Claudia Denkinger (308888)
Catharina Boehme (298634)
C. N. Paramasivan (358324)

May 2015

Enrollment of presumptive tuberculosis and drug resistant tuberculosis cases in baseline and inte...

Second-line treatment initiation within 6 mo, time to treatment, and site of treatment initiation by age, sex, HIV status, diagnostic facility, and diagnostic test (new rifampicin-resistant tuberculosis patients, 2013 cohort).

Helen Cox (66086)
Lindy Dickson-Hall (3768895)
Norbert Ndjeka (3768898)
Anja van’t Hoog (300467)
Alison Grant (790918)
Frank Cobelens (109566)
Wendy Stevens (62288)
Mark Nicol (3498533)

February 2017

Second-line treatment initiation within 6 mo, time to treatment, and site of treatment initiation...

Enrolment of HIV infected presumptive TB and DR TB cases under the study and TB and Rifampicin resistant TB case detection by Xpert MTB/RIF.

Neeraj Raizada (52447)
Kuldeep Singh Sachdeva (305148)
Achuthan Sreenivas (527535)
Shubhangi Kulsange (527538)
Radhey Shyam Gupta (689804)
Rahul Thakur (52453)
Puneet Dewan (342249)
Catharina Boehme (298634)
Chinnambedu Nainarappan Paramsivan (618814)

February 2015

Enrolment of HIV infected presumptive TB and DR TB cases under the study and TB and Rifampicin re...

Diagnostic and treatment initiation pathway for Multi-drug resistant TB (MDR- TB) under RNTCP.

Sarabjit S. Chadha (340345)
Sharath BN (340346)
Kishore Reddy (57711)
Jyothi Jaju (340348)
Vishnu PH (340350)
Sreenivas Rao (335239)
Malik Parmar (305152)
Srinath Satyanarayana (295839)
Kuldeep Singh Sachdeva (305148)
Nevin Wilson (302710)
Anthony D. Harries (76193)

February 2013

Diagnostic and treatment initiation pathway for Multi-drug resistant TB (MDR- TB) under RNTCP.</p

Rifampicin resistant HIV-infected TB cases diagnosed under the study.

Neeraj Raizada (52447)
Kuldeep Singh Sachdeva (305148)
Achuthan Sreenivas (527535)
Shubhangi Kulsange (527538)
Radhey Shyam Gupta (689804)
Rahul Thakur (52453)
Puneet Dewan (342249)
Catharina Boehme (298634)
Chinnambedu Nainarappan Paramsivan (618814)

February 2015

Abbreviations—OR = Odds Ratio, CI = Confidence intervalRifampicin resistant ...

Participants initiating TB treatment with confirmed TB (bacteriologically positive) and unconfirmed TB, overall and by HIV status (ITT analysis).

Helen S. Cox (80991)
Slindile Mbhele (665899)
Neisha Mohess (665900)
Andrew Whitelaw (23099)
Odelia Muller (359842)
Widaad Zemanay (665901)
Francesca Little (59851)
Virginia Azevedo (335962)
John Simpson (359843)
Catharina C. Boehme (197331)
Mark P. Nicol (197317)

November 2014

Participants initiating TB treatment with confirmed TB (bacteriologically positive) and unconfirm...

Sputum culture and phenotypic drug resistance of 243 Xpert rifampicin-resistant TB patients.

Arto Yuwono Soeroto (6411806)
Bony Wiem Lestari (6411809)
Prayudi Santoso (6411812)
Lidya Chaidir (103945)
Basti Andriyoko (6411815)
Bachti Alisjahbana (270243)
Reinout van Crevel (60606)
Philip C. Hill (20648)

February 2019

Sputum culture and phenotypic drug resistance of 243 Xpert rifampicin-resistant TB patients.</p

Detection of rifampicin resistant TB using Xpert MTB/RIF, solid and liquid media DST within the same individuals at four provincial laboratories.

Sanne Christine van Kampen (771338)
Aigul Tursynbayeva (771339)
Aliya Koptleuova (771340)
Zauresh Murzabekova (771341)
Lyazzat Bigalieva (771342)
Moldir Aubakirova (771343)
Svetlana Pak (771344)
Susan van den Hof (364556)

July 2015

Abbreviations: RIF, rifampicin; DST, drug-susceptibility testing.Detection of rifampicin r...

Diagnosis of MDR-TB in patients with risk factors for resistance.

Ye Minn Htun (6166160)
Tin Mi Mi Khaing (6166163)
Nay Myo Aung (6166166)
Yin Yin (2016565)
Zaw Myint (6166169)
Si Thu Aung (4707427)
Ngamphol Soonthornworasiri (3121773)
Udomsak Silachamroon (6166172)
Yuthichai Kasetjaroen (6166175)
Jaranit Kaewkungwal (190918)

December 2018

R-res; Rifampicin Resistance. TAF-I; Treatment after Failure Category I. TAF-II; Treatment after Fai...

Time to diagnosis and treatment of presumptive rifampicin-resistant TB using Xpert.

Arto Yuwono Soeroto (6411806)
Bony Wiem Lestari (6411809)
Prayudi Santoso (6411812)
Lidya Chaidir (103945)
Basti Andriyoko (6411815)
Bachti Alisjahbana (270243)
Reinout van Crevel (60606)
Philip C. Hill (20648)

February 2019

Time between microscopic TB diagnosis and patient presentation for Xpert examination (a), Xpert resu...

Number and proportion of culture positive tuberculosis cases with baseline drug susceptibility testing results, 2007–2016.

Pin-Hui Lee (541722)
Pei-Chun Chan (382044)
Yen-Ting Peng (6541703)
Po-Wei Chu (6541706)
Mei-Hua Wu (6541709)
Ruwen Jou (486507)
Ming-Chih Yu (309977)
Chou-Jui Lin (6541712)
Yi-Wen Huang (83101)
Shun-Tien Chien (382047)
Jen-Jyh Lee (207127)
Chen-Yuan Chiang (139384)

April 2019

Number and proportion of culture positive tuberculosis cases with baseline drug susceptibility testi...

Helen Cox (66086)
Lindy Dickson-Hall (3768895)
Norbert Ndjeka (3768898)
Anja van’t Hoog (300467)
Alison Grant (790918)
Frank Cobelens (109566)
Wendy Stevens (62288)
Mark Nicol (3498533)

February 2017

For previously diagnosed rifampicin-resistant tuberculosis patients, time from first recorded rif...

TB and rifampicin resistant-TB cases detected and initiated on treatment by each of the 4 diagnostic strategies, in a cohort 100,000 persons.

Sunil Khaparde (4419847)
Neeraj Raizada (52447)
Sreenivas Achuthan Nair (295840)
Claudia Denkinger (308888)
Kuldeep Singh Sachdeva (305148)
Chinnambedu Nainarappan Paramasivan (763725)
Virender Singh Salhotra (4419841)
Anna Vassall (144677)
Anja van't Hoog (4419844)

September 2017

TB and rifampicin resistant-TB cases detected and initiated on treatment by each of the 4 diagnos...

Enrollment of presumptive tuberculosis and drug resistant tuberculosis cases in baseline and intervention period of the study.

Kuldeep Singh Sachdeva (305148)
Neeraj Raizada (52447)
Achuthan Sreenivas (527535)
Anna H. van't Hoog (742534)
Susan van den Hof (364556)
Puneet K. Dewan (302713)
Rahul Thakur (52453)
R. S. Gupta (527537)
Shubhangi Kulsange (527538)
Bhavin Vadera (527536)
Ameet Babre (527539)
Christen Gray (121856)
Malik Parmar (305152)
Mayank Ghedia (527541)
Ranjani Ramachandran (110160)
Umesh Alavadi (527540)
Nimalan Arinaminpathy (88497)
Claudia Denkinger (308888)
Catharina Boehme (298634)
C. N. Paramasivan (358324)

May 2015

Enrollment of presumptive tuberculosis and drug resistant tuberculosis cases in baseline and inte...

Helen Cox (66086)
Lindy Dickson-Hall (3768895)
Norbert Ndjeka (3768898)
Anja van’t Hoog (300467)
Alison Grant (790918)
Frank Cobelens (109566)
Wendy Stevens (62288)
Mark Nicol (3498533)

February 2017

Second-line treatment initiation within 6 mo, time to treatment, and site of treatment initiation...

Enrolment of HIV infected presumptive TB and DR TB cases under the study and TB and Rifampicin resistant TB case detection by Xpert MTB/RIF.

Neeraj Raizada (52447)
Kuldeep Singh Sachdeva (305148)
Achuthan Sreenivas (527535)
Shubhangi Kulsange (527538)
Radhey Shyam Gupta (689804)
Rahul Thakur (52453)
Puneet Dewan (342249)
Catharina Boehme (298634)
Chinnambedu Nainarappan Paramsivan (618814)

February 2015

Enrolment of HIV infected presumptive TB and DR TB cases under the study and TB and Rifampicin re...

Diagnostic and treatment initiation pathway for Multi-drug resistant TB (MDR- TB) under RNTCP.

Sarabjit S. Chadha (340345)
Sharath BN (340346)
Kishore Reddy (57711)
Jyothi Jaju (340348)
Vishnu PH (340350)
Sreenivas Rao (335239)
Malik Parmar (305152)
Srinath Satyanarayana (295839)
Kuldeep Singh Sachdeva (305148)
Nevin Wilson (302710)
Anthony D. Harries (76193)

February 2013

Diagnostic and treatment initiation pathway for Multi-drug resistant TB (MDR- TB) under RNTCP.</p

Rifampicin resistant HIV-infected TB cases diagnosed under the study.

Neeraj Raizada (52447)
Kuldeep Singh Sachdeva (305148)
Achuthan Sreenivas (527535)
Shubhangi Kulsange (527538)
Radhey Shyam Gupta (689804)
Rahul Thakur (52453)
Puneet Dewan (342249)
Catharina Boehme (298634)
Chinnambedu Nainarappan Paramsivan (618814)

February 2015

Abbreviations—OR = Odds Ratio, CI = Confidence intervalRifampicin resistant ...

Participants initiating TB treatment with confirmed TB (bacteriologically positive) and unconfirmed TB, overall and by HIV status (ITT analysis).

Helen S. Cox (80991)
Slindile Mbhele (665899)
Neisha Mohess (665900)
Andrew Whitelaw (23099)
Odelia Muller (359842)
Widaad Zemanay (665901)
Francesca Little (59851)
Virginia Azevedo (335962)
John Simpson (359843)
Catharina C. Boehme (197331)
Mark P. Nicol (197317)

November 2014

Participants initiating TB treatment with confirmed TB (bacteriologically positive) and unconfirm...

Sputum culture and phenotypic drug resistance of 243 Xpert rifampicin-resistant TB patients.

Arto Yuwono Soeroto (6411806)
Bony Wiem Lestari (6411809)
Prayudi Santoso (6411812)
Lidya Chaidir (103945)
Basti Andriyoko (6411815)
Bachti Alisjahbana (270243)
Reinout van Crevel (60606)
Philip C. Hill (20648)

February 2019

Sputum culture and phenotypic drug resistance of 243 Xpert rifampicin-resistant TB patients.</p

Detection of rifampicin resistant TB using Xpert MTB/RIF, solid and liquid media DST within the same individuals at four provincial laboratories.

Sanne Christine van Kampen (771338)
Aigul Tursynbayeva (771339)
Aliya Koptleuova (771340)
Zauresh Murzabekova (771341)
Lyazzat Bigalieva (771342)
Moldir Aubakirova (771343)
Svetlana Pak (771344)
Susan van den Hof (364556)

July 2015

Abbreviations: RIF, rifampicin; DST, drug-susceptibility testing.Detection of rifampicin r...

Diagnosis of MDR-TB in patients with risk factors for resistance.

Ye Minn Htun (6166160)
Tin Mi Mi Khaing (6166163)
Nay Myo Aung (6166166)
Yin Yin (2016565)
Zaw Myint (6166169)
Si Thu Aung (4707427)
Ngamphol Soonthornworasiri (3121773)
Udomsak Silachamroon (6166172)
Yuthichai Kasetjaroen (6166175)
Jaranit Kaewkungwal (190918)

December 2018

R-res; Rifampicin Resistance. TAF-I; Treatment after Failure Category I. TAF-II; Treatment after Fai...

Time to diagnosis and treatment of presumptive rifampicin-resistant TB using Xpert.

Arto Yuwono Soeroto (6411806)
Bony Wiem Lestari (6411809)
Prayudi Santoso (6411812)
Lidya Chaidir (103945)
Basti Andriyoko (6411815)
Bachti Alisjahbana (270243)
Reinout van Crevel (60606)
Philip C. Hill (20648)

February 2019

Time between microscopic TB diagnosis and patient presentation for Xpert examination (a), Xpert resu...

Number and proportion of culture positive tuberculosis cases with baseline drug susceptibility testing results, 2007–2016.

Pin-Hui Lee (541722)
Pei-Chun Chan (382044)
Yen-Ting Peng (6541703)
Po-Wei Chu (6541706)
Mei-Hua Wu (6541709)
Ruwen Jou (486507)
Ming-Chih Yu (309977)
Chou-Jui Lin (6541712)
Yi-Wen Huang (83101)
Shun-Tien Chien (382047)
Jen-Jyh Lee (207127)
Chen-Yuan Chiang (139384)

April 2019

Number and proportion of culture positive tuberculosis cases with baseline drug susceptibility testi...

Treatment initiation status of bacteriologically confirmed rifampicin sensitive TB cases.

Abstract

Extracted data

Treatment initiation status of bacteriologically confirmed rifampicin sensitive TB cases.

Abstract

Extracted data

Related items

Related items